Recent News

• 10.19.2025 - European Society for Medical Oncology (ESMO) Congress
• 10.19.2025 - European Society for Medical Oncology (ESMO) Congress
• 09.05.2025 - NuCana Compliant with All Nasdaq Continued Listing Criteria
• 09.05.2025 - NuCana Compliant with All Nasdaq Continued Listing Criteria
• 09.05.2025 - NuCana Compliant with All Nasdaq Continued Listing Criteria
• 09.03.2025 - NuCana to Present Data on NUC-7738’s Synergy with PD-1 Inhibitors at the ESMO Congress 2025
• 09.03.2025 - NuCana to Present Data on NUC-7738’s Synergy with PD-1 Inhibitors at the ESMO Congress 2025
• 09.03.2025 - NuCana to Present Data on NUC-7738’s Synergy with PD-1 Inhibitors at the ESMO Congress 2025
• 08.20.2025 - NuCana Reports Second Quarter 2025 Financial Results and Provides Business Update
• 08.20.2025 - NuCana Reports Second Quarter 2025 Financial Results and Provides Business Update

Recent Filings

• 09.05.2025 - EX-99.1 EX-99.1
• 09.05.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 09.03.2025 - EX-99.1 EX-99.1
• 09.03.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 08.20.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 08.20.2025 - EX-99.1 EX-99.1